SeaBridge Investment Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-1,828
Closed -$219K – 262
2016
Q4
$219K Hold
1,828
– – 0.05% 143
2016
Q3
$205K Hold
1,828
– – 0.05% 143
2016
Q2
$226K Sell
1,828
-90
-5% -$10.9K 0.06% 143
2016
Q1
$216K Sell
1,918
-150
-7% -$15.6K 0.05% 150
2015
Q4
$225K Buy
2,068
+34
+2% +$3.89K 0.05% 145
2015
Q3
$203K Hold
2,034
– – 0.05% 142
2015
Q2
$232K Hold
2,034
– – 0.05% 138
2015
Q1
$213K Buy
+2,034
New +$217K 0.04% 144
2014
Q3
– Sell
-3,101
Closed -$518K – 209
2014
Q2
$518K Buy
+3,101
New +$552K 0.11% 113

Other funds holding CLB

SeaBridge Investment Advisors's CLB Position: Q1 2017 in Review

SeaBridge Investment Advisors sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 1,828 shares — an estimated $219K sold.

SeaBridge Investment Advisors first reported a position in CLB in Q2 2014 and held it in 9 quarters. The position peaked at $518K in Q2 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • SeaBridge Investment Advisors reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • SeaBridge Investment Advisors sold 1,828 Core Laboratories shares in Q1 2017, an estimated $219K.
  • SeaBridge Investment Advisors first reported a position in Core Laboratories in Q2 2014 and held it in 9 quarters.
  • SeaBridge Investment Advisors's Core Laboratories position peaked at $518K in Q2 2014.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on SeaBridge Investment Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.